1. Araki, S., and Mawatari, S., 1971, Ouabain and erythrocyte-ghost adenosine triphosphatase. Effects in human muscular dystrophies, Arch. Neurol. 24:187–190.
2. Bertorini, T. E., Bhattacharya, S. K., Palmieri, G. M. A., Chesney, C. M., Pifer, D., and Baker, B., 1982, Muscle calcium and magnesium content in Duchenne muscular dystrophy, Neurology 32: 1088–1092.
3. Bertorini, T. E., Cornelio, F., Bhattacharya, S. K., Palmieri, G. M. A., Dones, I., Dworzak, F., and Brambati, B., 1984, Calcium and magnesium content in fetuses at risk and prenecrotic Duchenne muscular dystrophy, Neurology 34:1436–1440.
4. Bhattacharya, S. K., and Crawford, A. J., 1985, Preliminary evidence of magnesium depletion and excessive calcium accumulation in human myoblasts of dystrophic origin, Soc. Neurosci. Abstr. 11:1302.
5. Bhattacharya, S. K., and Crawford, A. J., 1986, Beneficial effects of adenosine triphosphate-magnesium chloride administration in muscular dystrophy, Soc. Neurosci. Abstr. 12:264.